SMTL ID : 8eqe.1

Co-crystal structure of PERK with compound 26

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.56 Å

Oligo State

monomer

Ligands

1 x WQ2: (2R)-N-[(4M)-4-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-3-methylphenyl]-2-hydroxy-2-[3-(trifluoromethyl)phenyl]acetamide(Non-covalent)

WQ2.1: 18 residues within 4Å: Chain A: L.27, V.35, A.48, V.68, L.71, A.72, V.80, Y.82, I.109, M.111, Q.112, L.113, C.114, F.167, G.177, D.178, F.179, L.181 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.35, A:L.71, A:L.71, A:V.80, A:Y.82, A:L.113, A:D.178 Hydrogen bonds: A:Q.112, A:C.114, A:D.178, A:F.179 pi-Stacking: A:F.167, A:F.167

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stokes, M.E. et al., Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors. Pharmaceutics (2022)

Release Date

2022-11-30

Peptides

Eukaryotic translation initiation factor 2-alpha kinase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Eukaryotic translation initiation factor 2-alpha kinase 3

Related Entries With Identical Sequence